These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2080653

  • 1. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E, Pollack P, Seebacher C, Riedel H.
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M, Formanek I.
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [Abstract] [Full Text] [Related]

  • 3. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P, Rocchi E, Cassanelli M, Pietrangelo A, Coppini M, Ventura E.
    Minerva Med; 1984 Mar 10; 75(9-10):469-74. PubMed ID: 6709223
    [Abstract] [Full Text] [Related]

  • 4. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L, Di Padova C, Cainelli T, Reseghetti A, Di Padova F, Rovagnati P, Cantoni L.
    Photodermatol; 1984 Dec 10; 1(6):286-92. PubMed ID: 6398430
    [Abstract] [Full Text] [Related]

  • 5. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda.
    Tsega E.
    Q J Med; 1987 Nov 10; 65(247):953-7. PubMed ID: 3455550
    [Abstract] [Full Text] [Related]

  • 6. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens.
    Haberman HF, Rosenberg F, Menon IA.
    Can Med Assoc J; 1975 Oct 04; 113(7):653-5. PubMed ID: 1181022
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E, Seebacher C, Riedel H, Kemmer C.
    Hautarzt; 1986 Apr 04; 37(4):210-6. PubMed ID: 3009356
    [Abstract] [Full Text] [Related]

  • 8. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S, Seubert A, Stella AM, Guzman H, Batlle A.
    Z Hautkr; 1990 Mar 04; 65(3):223-5. PubMed ID: 2339575
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
    Malina L, Chlumský J.
    Acta Derm Venereol; 1981 Mar 04; 61(4):346-50. PubMed ID: 6173993
    [Abstract] [Full Text] [Related]

  • 10. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I, Nagy E.
    Z Hautkr; 1980 Jun 15; 55(12):813-6. PubMed ID: 7415362
    [Abstract] [Full Text] [Related]

  • 11. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO.
    Z Hautkr; 1988 Apr 15; 63(4):282-9. PubMed ID: 3291437
    [Abstract] [Full Text] [Related]

  • 12. Effect of nicotinic acid administration on serum levels of bilirubin and iron in patients with porphyria cutanea tarda.
    Gentile S, Ayala F, Orlando C, Santoianni P, Budillon G.
    Scand J Clin Lab Invest; 1988 Nov 15; 48(7):641-5. PubMed ID: 3201096
    [Abstract] [Full Text] [Related]

  • 13. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
    Stölzel U, Köstler E, Schuppan D, Richter M, Wollina U, Doss MO, Wittekind C, Tannapfel A.
    Arch Dermatol; 2003 Mar 15; 139(3):309-13. PubMed ID: 12622622
    [Abstract] [Full Text] [Related]

  • 14. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C, Muniesa A.
    Med Cutan Ibero Lat Am; 1980 Mar 15; 8(4-6):139-45. PubMed ID: 7024672
    [Abstract] [Full Text] [Related]

  • 15. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E, Jabłońska-Kaszewska I, Bielawski KP, Falkiewicz B.
    Med Sci Monit; 2001 May 15; 7 Suppl 1():190-6. PubMed ID: 12211718
    [Abstract] [Full Text] [Related]

  • 16. [Does paraneoplastic porphyria cutanea tarda exist?].
    Köstler E.
    Dtsch Z Verdau Stoffwechselkr; 1988 May 15; 48(1):35-40. PubMed ID: 3371236
    [Abstract] [Full Text] [Related]

  • 17. Chloroquine in the treatment of porphyria cutanea tarda.
    Tsega E, Besrat A, Damtew B, Seyoum E, Landells JW.
    Trans R Soc Trop Med Hyg; 1981 May 15; 75(3):401-4. PubMed ID: 7324107
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS.
    Vestn Dermatol Venerol; 1984 Oct 15; (10):20-3. PubMed ID: 6516569
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.